chr3-189737892-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003722.5(TP63):​c.191+24T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0496 in 1,613,296 control chromosomes in the GnomAD database, including 2,544 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.035 ( 197 hom., cov: 32)
Exomes 𝑓: 0.051 ( 2347 hom. )

Consequence

TP63
NM_003722.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.761

Publications

3 publications found
Variant links:
Genes affected
TP63 (HGNC:15979): (tumor protein p63) This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016]
TP63 Gene-Disease associations (from GenCC):
  • ADULT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • limb-mammary syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • Rapp-Hodgkin syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • premature ovarian failure 21
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • split hand-foot malformation 4
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • EEC syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • split hand-foot malformation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-189737892-T-C is Benign according to our data. Variant chr3-189737892-T-C is described in ClinVar as Benign. ClinVar VariationId is 259131.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.058 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TP63NM_003722.5 linkc.191+24T>C intron_variant Intron 2 of 13 ENST00000264731.8 NP_003713.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TP63ENST00000264731.8 linkc.191+24T>C intron_variant Intron 2 of 13 1 NM_003722.5 ENSP00000264731.3

Frequencies

GnomAD3 genomes
AF:
0.0354
AC:
5391
AN:
152100
Hom.:
197
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00789
Gnomad AMI
AF:
0.0286
Gnomad AMR
AF:
0.0156
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0168
Gnomad FIN
AF:
0.0557
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0595
Gnomad OTH
AF:
0.0287
GnomAD2 exomes
AF:
0.0379
AC:
9475
AN:
250330
AF XY:
0.0377
show subpopulations
Gnomad AFR exome
AF:
0.00727
Gnomad AMR exome
AF:
0.0162
Gnomad ASJ exome
AF:
0.00358
Gnomad EAS exome
AF:
0.0000546
Gnomad FIN exome
AF:
0.0553
Gnomad NFE exome
AF:
0.0611
Gnomad OTH exome
AF:
0.0385
GnomAD4 exome
AF:
0.0510
AC:
74549
AN:
1461078
Hom.:
2347
Cov.:
31
AF XY:
0.0501
AC XY:
36421
AN XY:
726834
show subpopulations
African (AFR)
AF:
0.00774
AC:
259
AN:
33460
American (AMR)
AF:
0.0167
AC:
745
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.00452
AC:
118
AN:
26118
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39614
South Asian (SAS)
AF:
0.0152
AC:
1314
AN:
86236
European-Finnish (FIN)
AF:
0.0571
AC:
3045
AN:
53356
Middle Eastern (MID)
AF:
0.0261
AC:
150
AN:
5758
European-Non Finnish (NFE)
AF:
0.0598
AC:
66493
AN:
1111476
Other (OTH)
AF:
0.0401
AC:
2423
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3281
6561
9842
13122
16403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2376
4752
7128
9504
11880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0354
AC:
5392
AN:
152218
Hom.:
197
Cov.:
32
AF XY:
0.0339
AC XY:
2526
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.00787
AC:
327
AN:
41544
American (AMR)
AF:
0.0156
AC:
239
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.0172
AC:
83
AN:
4830
European-Finnish (FIN)
AF:
0.0557
AC:
591
AN:
10604
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0595
AC:
4045
AN:
67984
Other (OTH)
AF:
0.0284
AC:
60
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
255
510
766
1021
1276
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0542
Hom.:
426
Bravo
AF:
0.0317
Asia WGS
AF:
0.00808
AC:
30
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.9
DANN
Benign
0.73
PhyloP100
0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34875865; hg19: chr3-189455681; API